CAREDX INC (CDNA)
US14167L1035 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to CDNA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.65. This target is 65.12% above the current price.
CDNA was analyzed by 13 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CDNA.
In the previous month the buy percentage consensus was at a similar level.
CDNA was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-17 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-11-09 | Stephens & Co. | Upgrade | Equal-Weight -> Overweight |
| 2023-09-26 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-08-15 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-07-11 | Raymond James | Maintains | Market Perform -> Market Perform |
| 2023-05-11 | BTIG | Downgrade | Buy -> Neutral |
| 2023-03-07 | Stephens & Co. | Downgrade | Overweight -> Equal-Weight |
| 2023-03-07 | Goldman Sachs | Maintains | Buy |
| 2023-03-03 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2023-03-03 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2023-02-28 | BTIG | Maintains | Buy |
| 2023-02-28 | Stephens & Co. | Reiterate | Overweight |
| 2023-02-28 | Goldman Sachs | Maintains | Buy |
| 2023-02-28 | Craig-Hallum | Maintains | Buy |
| 2023-02-16 | Stephens & Co. | Reiterate | Overweight |
| 2023-02-06 | Goldman Sachs | Maintains | Buy |
| 2023-01-31 | Raymond James | Maintains | Strong Buy |
| 2022-11-08 | Raymond James | Maintains | Strong Buy |
| 2022-11-07 | BTIG | Maintains | Buy |
| 2022-11-04 | Goldman Sachs | Maintains | Buy |
| 2022-08-10 | Raymond James | Maintains | Strong Buy |
| 2022-05-06 | Raymond James | Maintains | Strong Buy |
| 2022-04-25 | Stephens & Co. | Initiate | Overweight |
| 2022-02-25 | Raymond James | Maintains | Strong Buy |
| 2021-10-29 | Raymond James | Maintains | Strong Buy |
| 2021-06-28 | Raymond James | Maintains | Strong Buy |
| 2021-06-03 | Goldman Sachs | Initiate | Buy |
| 2021-05-06 | Raymond James | Maintains | Strong Buy |
| 2021-02-25 | Raymond James | Maintains | Strong Buy |